ASTH Astrana Health, Inc.
8-K Current Report
Filed: March 2, 2026
Industrials
Services-Management Consulting ServicesAstrana Health, Inc. (ASTH) 8-K current report filed with SEC EDGAR on March 2, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items3 items
- Item 7.01: Regulation FD Disclosure
- Item 2.02: Results of Operations and Financial Condition
- Item 8.01: Other Events
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Q1 2025 earnings results disclosed via press release (Exhibit 99.1) — refer to exhibit for all financial figures
- • Filing structured as Reg FD-compliant disclosure; press release not subject to Section 18 liability
Item 7.01 · Regulation FD Disclosure
- • Astrana Health furnishing Reg FD disclosure — signals management is sharing material non-public info with the broader market to ensure fair access
- • Filing explicitly "not filed" under Exchange Act Section 18 — limits shareholder litigation liability for the disclosed information
Item 8.01 · Other Events
- • Buyback authorization doubled from $50M to $100M, signaling board confidence in stock's intrinsic value
- • 633,844 shares repurchased in Q4 2025; $35.9M remained under old program as of Dec 31, 2025
Other Astrana Health, Inc. 8-K Filings
Get deeper insights on Astrana Health, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.